Company Quantum Genomics

Equities

ALQGC

FR0011648971

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 09:10:45 2024-04-23 am EDT			5-day change	1st Jan Change
0.1118 ^EUR	+0.54%		+1.45%	+5.47%

Mar. 13	Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

All sales are abroad.

Number of employees: 3

EUR in Million	2022	Weight	2023	Weight	Delta
Innovative Medicines 100.0 %	1	100.0 %	0	100.0 %	-98.34%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	1	100.0 %	0	100.0 %	-98.34%

Managers	Title	Age	Since
Jean-Philippe Milon CEO	Chief Executive Officer	63	-
Lionel Ségard FOU	Founder	56	05-12-22
Benoît Gueugnon DFI	Director of Finance/CFO	-	18-06-30
Bruno Besse CTO	Chief Tech/Sci/R&D Officer	-	17-02-28
Fabrice Balavoine CTO	Chief Tech/Sci/R&D Officer	-	-
Sarah Merlen-Boulenger LAW	General Counsel	-	22-05-03

Members of the board	Title	Age	Since
Lionel Ségard FOU	Founder	56	05-12-22
François Pelen BRD	Director/Board Member	66	-
Jean-Philippe Milon CEO	Chief Executive Officer	63	-
Carole Wassermann BRD	Director/Board Member	58	-
François Durvye BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	34,854,981	30,403,091 ( 87.23 %)	0	87.23 %

Name	Equities	%	Valuation
Vatel Capital SAS 0.9688 %	337,673	0.9688 %	39 167 €
Ecofi Investissements SA 0.1989 %	69,330	0.1989 %	8 042 €
Lemanik Asset Management SA 0.1533 %	53,420	0.1533 %	6 196 €
Lyxor International Asset Management SAS 0.0954 %	33,246	0.0954 %	3 856 €

Quantum Genomics SA

33 Rue Marbeuf

75008, Paris

+33 1 85 34 77 70

http://www.quantum-genomics.com

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

0.1112 EUR

Average target price

0.1 EUR

Spread / Average Target

-10.07%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUANTUM GENOMICS	+5.47%	8.25M
IQVIA HOLDINGS INC.	+3.13%	42.11B
LONZA GROUP AG	+48.83%	40.08B
MODERNA, INC.	+8.49%	40B
CELLTRION, INC.	-10.82%	26.87B
ICON PUBLIC LIMITED COMPANY	+8.26%	24.58B
ALNYLAM PHARMACEUTICALS, INC.	-23.69%	18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.58%	11.94B
MEDPACE HOLDINGS, INC.	+32.83%	11.66B
UNITED THERAPEUTICS CORPORATION	+6.63%	11.01B

Other Biotechnology & Medical Research